Sabra Healthcare REIT Inc (NASDAQ: SBRA) has a price-to-earnings ratio that is above its average at 40.55x. The stock has a 36-month beta value of 1.24. Opinions on the stock are mixed, with 7 analysts rating it as a “buy,” 1 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for SBRA is 232.54M, and at present, short sellers hold a 7.71% of that float. On January 15, 2025, the average trading volume of SBRA was 2.05M shares.
SBRA) stock’s latest price update
The stock price of Sabra Healthcare REIT Inc (NASDAQ: SBRA) has jumped by 1.14 compared to previous close of 16.61. Despite this, the company has seen a gain of 1.02% in its stock price over the last five trading days. seekingalpha.com reported 2025-01-04 that Sabra Health Care REIT gets rated buy, agreeing with consensus, and driven heavily by macro-level demand forecasts for skilled nursing facilities. The stock is undervalued on forward P/FFO vs key peers, and is trading close to its moving average now. The firm has investment-grade ratings from Fitch and Moody’s agencies.
SBRA’s Market Performance
SBRA’s stock has risen by 1.02% in the past week, with a monthly drop of -4.98% and a quarterly drop of -6.77%. The volatility ratio for the week is 2.59% while the volatility levels for the last 30 days are 2.43% for Sabra Healthcare REIT Inc The simple moving average for the last 20 days is -1.32% for SBRA’s stock, with a simple moving average of 1.90% for the last 200 days.
Analysts’ Opinion of SBRA
Many brokerage firms have already submitted their reports for SBRA stocks, with JMP Securities repeating the rating for SBRA by listing it as a “Mkt Outperform.” The predicted price for SBRA in the upcoming period, according to JMP Securities is $20 based on the research report published on January 07, 2025 of the current year 2025.
Mizuho, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $20. The rating they have provided for SBRA stocks is “Neutral” according to the report published on December 05th, 2024.
Wells Fargo gave a rating of “Overweight” to SBRA, setting the target price at $20 in the report published on October 01st of the previous year.
SBRA Trading at -6.34% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.13% of loss for the given period.
Volatility was left at 2.43%, however, over the last 30 days, the volatility rate increased by 2.59%, as shares sank -3.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.20% lower at present.
During the last 5 trading sessions, SBRA rose by +1.02%, which changed the moving average for the period of 200-days by +15.23% in comparison to the 20-day moving average, which settled at $17.02. In addition, Sabra Healthcare REIT Inc saw -3.00% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBRA starting from Cusack Catherine, who purchase 7,000 shares at the price of $14.43 back on May 22 ’24. After this action, Cusack Catherine now owns 46,385 shares of Sabra Healthcare REIT Inc, valued at $101,010 using the latest closing price.
FOSTER MICHAEL J, the Director of Sabra Healthcare REIT Inc, sale 10,000 shares at $14.68 during a trade that took place back on May 14 ’24, which means that FOSTER MICHAEL J is holding 63,923 shares at $146,830 based on the most recent closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- 0.38 for the present operating margin
- 0.52 for the gross margin
The net margin for Sabra Healthcare REIT Inc stands at 0.14. The total capital return value is set at 0.07. Equity return is now at value 3.46, with 1.81 for asset returns.
Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.91. The interest coverage ratio of the stock is 2.02.
Currently, EBITDA for the company is 311.81 million with net debt to EBITDA at 5.75. When we switch over and look at the enterprise to sales, we see a ratio of 9.25. The receivables turnover for the company is 5.71for trailing twelve months and the total asset turnover is 0.13.
Conclusion
To sum up, Sabra Healthcare REIT Inc (SBRA) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
